Soft Tissue Neoplasms
10
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
10.0%
1 terminated out of 10 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Stress and Anxiety Before Biopsy, After Biopsy Results, and During Treatment in Patients With Suspected Bone or Soft Tissue Cancer
Study of MEK162 for Children With Low-Grade Gliomas
Investigation Into the Safety and Efficacy of ICG-Labeled Fluorescence Imaging Technology in Guiding the Resection of Bone and Soft Tissue Tumors
Ewing Sarcoma Family of Tumors (ESFT): A 15-year Experience From a Tertiary Care Cancer Center in Upper Egypt
Malignant Pediatric Soft Tissue & Bone Tumors of the Extremities: A Retrospective Study
Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors
Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients
Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Radiofrequency Ablation of Painful Soft Tissue Neoplasms
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans